A UT Southwestern Medical Center quality improvement team led a large-scale, multispecialty project in partnership with the ...

Such techniques can be automatically applied using implantable cardioverter defibrillators (ICDs) and offer the potential for painless termination of ventricular tachycardia (VT). Reduction in ...

KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) is planning to raise $150 million in an initial public offering (IPO) on Thursday, March 6th, IPO Scoop reports. The company will be issuing 10,000,000 shares ...

Following a hefty raise by Beta Bionics last month, Kestra’s IPO means medtech has enjoyed a strong 2025 start for listings.

AI innovations look set to transform healthcare by facilitating precision medicine, improving diagnostic accuracy and ...

The wearable cardiac monitor and defibrillator developer Kestra Medical Technologies aims to raise about $154 million by ...

Implantable cardiac devices play a significant role in decreasing the morbidity and mortality in patients with cardiovascular disease. Tissue-device interactions leading to systemic ...

NEW YORK (AP) — The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings.

Heart attacks and cardiac arrest differ in causes, symptoms, and treatments. Learn how recognizing these emergencies improves ...

Inflammation biotech Apimeds Pharmaceuticals US ( APUS) is tentatively scheduled to raise $20 million at a $58 million market ...